Neuropsychology
Attentional Impairments in Huntington’s Disease: A
Specific Deficit for the Executive Conflict
Pierre Maurage, Alexandre Heeren, Magali Lahaye, Anne Jeanjean, Lamia Guettat, Christine
Verellen-Dumoulin, Stéphane Halkin, Joël Billieux, and Eric Constant
Online First Publication, February 27, 2017. http://dx.doi.org/10.1037/neu0000321
CITATION
Maurage, P., Heeren, A., Lahaye, M., Jeanjean, A., Guettat, L., Verellen-Dumoulin, C., Halkin, S.,
Billieux, J., & Constant, E. (2017, February 27). Attentional Impairments in Huntington’s Disease: A
Specific Deficit for the Executive Conflict. Neuropsychology. Advance online publication.
http://dx.doi.org/10.1037/neu0000321
Neuropsychology
2017, Vol. 0, No. 999, 000
© 2017 American Psychological Association
0894-4105/17/$12.00 http://dx.doi.org/10.1037/neu0000321
This document is copyrighted by the American Psychological Association or one of its allied publishers.
This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
Attentional Impairments in Huntington’s Disease: A Specific Deficit for
the Executive Conflict
Pierre Maurage
Alexandre Heeren
Université catholique de Louvain
Université catholique de Louvain and Harvard University
Magali Lahaye and Anne Jeanjean
Lamia Guettat
Saint-Luc University Hospital
Beauvallon Psychiatric Hospital, Saint-Servais, Belgium
Christine Verellen-Dumoulin
Stéphane Halkin
Institute of Pathology and Genetics, Gosselies, Belgium
Liège University Hospital
Joël Billieux
Eric Constant
Université catholique de Louvain and University of Luxembourg
Saint-Luc University Hospital
Objective: Huntington’s disease (HD) is characterized by motor and cognitive impairments including memory, executive, and attentional functions. However, because earlier studies relied on
multidetermined attentional tasks, uncertainty still abounds regarding the differential deficit across
attentional subcomponents. Likewise, the evolution of these deficits during the successive stages of
HD remains unclear. The present study simultaneously explored 3 distinct networks of attention
(alerting, orienting, executive conflict) in preclinical and clinical HD. Method: Thirty-eight HD
patients (18 preclinical) and 38 matched healthy controls completed the attention network test, an
integrated and theoretically grounded task assessing the integrity of 3 attentional networks. Results:
Preclinical HD was not characterized by any attentional deficit compared to controls. Conversely,
clinical HD was associated with a differential deficit across the 3 attentional networks under
investigation, showing preserved performance for alerting and orienting networks but massive and
specific impairment for the executive conflict network. This indexes an impaired use of executive
control to resolve the conflict between task-relevant stimuli and interfering task-irrelevant ones.
Conclusion: Clinical HD does not lead to a global attentional deficit but rather to a specific
impairment for the executive control of attention. Moreover, the absence of attentional deficits in
preclinical HD suggests that these deficits are absent at the initial stages of the disease. In view of
their impact on everyday life, attentional deficits should be considered in clinical contexts.
Therapeutic programs improving the executive control of attention by neuropsychology and neuromodulation should be promoted.
All authors report no competing financial interests or potential conflicts of
interest and no connection with pharmaceutical industries. Pierre Maurage, as
a research associate, and Alexandre Heeren are funded by the Belgian Fund for
Scientific Research (F.R.S.-FNRS), and Magali Lahaye is funded by a Seed
Fund grant from the European Huntington’s Disease Network. A Seed Fund
grant from the European Huntington’s Disease Network (Project 332) was also
awarded to Eric Constant and Pierre Maurage. This work received support as
well from the Belgian Foundation for Vocation (Vocatio) and the WBI World
Excellence Grant in Life Sciences–BIOWIN (sub/2015/228106243177), both
awarded to Alexandre Heeren. These funds did not exert any editorial direction
on or censorship of any part of this article.
Correspondence concerning this article should be addressed to Pierre Maurage, Laboratory of Experimental Psychopathology, Psychological Sciences
Research Institute, Université catholique de Louvain, 10 Place du Cardinal
Mercier, B-1348 Louvain-la-Neuve, Belgium. E-mail: pierre.maurage@
uclouvain.be
Pierre Maurage, Laboratory for Experimental Psychopathology, Psychological Sciences Research Institute, Université catholique de Louvain; Alexandre
Heeren, Laboratory for Experimental Psychopathology, Psychological Sciences Research Institute, Université catholique de Louvain, and Department of
Psychology, Harvard University; Magali Lahaye, Department of Pediatric
Hematology and Oncology, Saint-Luc University Hospital; Anne Jeanjean,
Department of Neurology, Saint-Luc University Hospital; Lamia Guettat,
Department of Neuropsychiatry, Beauvallon Psychiatric Hospital, SaintServais, Belgium; Christine Verellen-Dumoulin, Institute of Pathology and
Genetics, Gosselies, Belgium; Stéphane Halkin, Department of Psychiatry,
Liège University Hospital; Joël Billieux, Laboratory for Experimental Psychopathology, Psychological Sciences Research Institute, Université catholique de Louvain and Institute for Health and Behavior, Integrative Research Unit on Social and
Individual Development (INSIDE), University of Luxembourg; Eric Constant,
Department of Psychiatry, Saint-Luc University Hospital.
1
2
MAURAGE ET AL.
This document is copyrighted by the American Psychological Association or one of its allied publishers.
This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
General Scientific Summary
Huntington’s disease (HD) centrally leads to motor dysfunction but is also characterized by cognitive
deficits. Attentional abilities, while important for efficient cognitive functioning, have not been fully
explored in HD, and their differential impairment between pre-clinical and clinical HD has not been
determined. We measured attentional abilities in pre-clinical and clinical HD, with a task separately
exploring alerting (i.e., sustaining a readiness state to be prepared for incoming stimuli), orienting
(i.e., selecting the incoming information by engaging, disengaging, and shifting attentional resources)
and executive control (i.e., top-down control of attention and conflict resolution) attentional networks. Results showed that clinical HD is associated with a specific impairment for executive
control, while alerting and orienting are preserved. No deficits for attentional networks were
observed in pre-clinical HD, suggesting that attentional deficits might differentiate the successive
stages of HD, and that rehabilitation programs focusing on executive control should be developed in
clinical HD.
Keywords: Huntington’s disease, attentional networks, executive control, attention network test
Supplemental materials: http://dx.doi.org/10.1037/neu0000321.supp
Huntington’s disease (HD) is a genetic neurodegenerative disease mainly associated with massive motor impairments (Van
Duijn, Kingma, & van der Mast, 2007). At the cerebral level, these
movement disorders are related to progressive neurodegeneration
in basal ganglia, particularly in the striatum and its spiny projections toward globus pallidus and substantia nigra (Fusco et al.,
1999; Ross & Tabrizi, 2011; Sapp et al., 1997). However, the brain
deficits go far beyond motor regions: White matter atrophy is
observed from early disease stages (Reading et al., 2005), followed
by marked brain atrophy in the thalamus, hypothalamus, and
occipital cortex as well as in frontal regions (Eidelberg & Surmeier, 2011; Rosenblatt, 2007; Wolf & Klöppel, 2013). These
cerebral modifications lead to wide-range cognitive impairments
in preclinical (i.e., asymptomatic persons carrying the HD’s gene)
and clinical (i.e., symptomatic individuals presenting motor, cognitive, and/or psychiatric impairments) patients (Ross & Tabrizi,
2011; Sturrock & Leavitt, 2010). Accordingly, clinical HD patients
exhibit impaired visuomotor (Aron et al., 2003; Say et al., 2011),
memory (Lawrence et al., 1996), and executive (Beglinger et al.,
2010; Beste, Saft, Andrich, Gold, & Falkenstein, 2008) processes.
Yet evidence remains inconsistent in preclinical HD, particularly
regarding executive impairments (Brandt et al., 2008; O’Rourke et
al., 2011).
Of critical importance for practitioners, these cognitive alterations
result in a significant burden for patients through lower educational
and professional achievement, everyday occupational impairments,
and reduced treatment compliance (Beglinger et al., 2012; Paulsen &
Long, 2014). Therefore, a comprehensive understanding of these
cognitive alterations is needed and would help clinicians to select
appropriate therapeutic targets whose restoration may improve patients’ everyday life. Moreover, such advances may help to identify
potential neurocognitive biomarkers of disease progression acting as
a tipping point in the preclinical to clinical transition (Stout et al.,
2011). The discrepancies observed in earlier studies and the use of
multidetermined neuropsychological tasks (Brandt et al., 2008) currently hamper the identification of such cognitive biomarkers. However, as recently proposed (Dumas, van den Bogaard, Middelkoop, &
Roos, 2013), attentional processes are an underexplored but promising way to differentiate preclinical and clinical HD (Bachoud-Lévi et
al., 2001; Lemiere, Decruyenaere, Evers-Kiebooms, Vandenbussche,
& Dom, 2004), thus constituting a potential candidate to become a
cognitive biomarker.
Accordingly, a dissociated pattern with marked attentional dysfunction in clinical HD but preserved attentional processes in preclinical HD has been proposed. Whereas early works had spotted largescale attentional dysfunctions in clinical HD (e.g., Sprengelmeyer, Lange, & Hömberg, 1995), recent ones have more
specifically indicated impaired visuospatial (Bublak, Redel, &
Finke, 2006), divided (Thompson et al., 2010), selective
(Georgiou-Karistianis et al., 2012), and sustained (Duff et al.,
2010) attention, thus confirming large-range attentional impairments in HD. Several studies have further illuminated that
clinical HD is associated with preserved attention orientation
(Beste et al., 2008) but impaired ability in the voluntarily
disengagement of attentional focus (Couette, Bachoud-Levi,
Brugieres, Sieroff, & Bartolomeo, 2008; Georgiou, Bradshaw,
Phillips, & Chiu, 1996) and in the inhibitory control of attention
(Henderson et al., 2011). This proposal that clinical HD would
mostly be related to impairments for the executive control of
attention is consistent with neuroimaging results, because this
ability relies on the integrity of frontal regions and frontostriatal circuits, known to be impaired in HD (GeorgiouKaristianis et al., 2012; Wolf & Klöppel, 2013).
In contrast, individuals with preclinical HD did not evidence such
a deficit (Lemiere et al., 2004; Malejko et al., 2014), despite some
inconsistent results (Verny et al., 2007; Wolf et al., 2011). Yet, most
of these studies did not compare preclinical and clinical HD. Moreover, the four studies including such a comparison yielded inconsistent findings. On the one hand, two studies (Peretti et al., 2008;
Peretti, Peretti, Chouinard, & Chouinard, 2010) depicted preserved
exogenous but impaired endogenous attention in clinical and preclinical HD, which was interpreted as a specific deficit for voluntary
attentional abilities. On the other hand, Hart et al. (2012) showed
distinct performances in a sustained attention task, namely reduced
attentional control in clinical HD with no deficit in preclinical HD.
These results have been recently confirmed by a 3-year follow-up
study showing a linear decrease of attentional performance in clinical
HD over time, whereas preclinical HD patients were able to maintain
This document is copyrighted by the American Psychological Association or one of its allied publishers.
This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
ATTENTIONAL NETWORKS IN HUNTINGTON’S DISEASE
a preserved performance (Hart et al., 2015). Despite their useful
insights, these studies focused on a specific and basic component of
attention, so their generalizability toward other attentional subsystems
remains unknown. More globally, earlier studies comparing preclinical and clinical HD did not control for psychopathological
comorbidities (despite their influence on attention; Heeren,
Maurage, & Philippot, 2015; Lyche, Jonassen, Stiles, Ulleberg,
& Landrø, 2011). Finally, earlier studies did not propose an
integrated task simultaneously evaluating the different attentional subcomponents. Using such an integrated task in preclinical and clinical HD would thus constitute an important step
toward the understanding of this impairment.
The attention network test (ANT; Fan, McCandliss, Sommer,
Raz, & Posner, 2002), based on a cognitive model of attention
(Petersen & Posner, 2012; Posner & Petersen, 1990), constitutes an
effective tool to simultaneously explore various attentional subcomponents. Indeed, it provides an integrated assessment of three
independent networks: (a) alerting, that is, reaching and sustaining
a global high sensitivity or readiness state to be prepared for
incoming stimuli; (b) orienting, that is, selecting the incoming
information by engaging, disengaging, and shifting the attentional
resources from one stimulation to another; and (c) executive conflict, that is, top-down control of attention and conflict resolution.
By evaluating these three components simultaneously, this task
allows the direct exploration of the differential deficit across
attentional subcomponents. This model has been reinforced by a
neuroscience approach that identified specific brain circuits associated with each network: superior temporal and thalamic activations for alerting; superior parietal lobule and fusiform gyrus
activations for orienting; and thalamic, cingulate and superiorinferior frontal gyri activations for executive conflict (Fan, McCandliss, Fossella, Flombaum, & Posner, 2005; MacLeod et al.,
2010; Visintin et al., 2015).
The ANT has been widely used to characterize attentional
deficits in neuropsychiatric (Maurage, de Timary, Billieux, Collignon, & Heeren, 2014; Orellana, Slachevsky, & Peña, 2012) and
neurological (Fernández et al., 2011; Fernandez-Duque & Black,
2006; Urbanek et al., 2010) disorders but also recently in movement disorders such as Wilson’s and Parkinson’s diseases (associated to alerting and orienting impairments, respectively; Han et
al., 2014; Zhou et al., 2012). This task is thus a reliable tool to
explore the differential attentional impairments across neuropsychiatric and neurological syndromes, but it has not to date been
applied to HD. The main aim of the present study was thus to
measure attentional processes in preclinical and clinical HD with
the ANT. In view of earlier studies showing executive functions
deficits in clinical HD (Dumas et al., 2013) and suggesting a
specific deficit for attentional control (Couette et al., 2008; Henderson et al., 2011), it can be hypothesized that clinical HD will be
associated with attentional impairments, particularly for the executive conflict network. This hypothesis is reinforced by the fact
that this attentional network mostly relies on thalamic and frontal
areas (Fan et al., 2005), which are particularly affected by HD
neurodegeneration (Eidelberg & Surmeier, 2011; Wolf & Klöppel,
2013). Conversely, preclinical HD might show a global preservation of attention, because attentional functions appear quite preserved in this population (Malejko et al., 2014).
3
Method
Participants
Thirty-eight individuals (15 women) with a genetically confirmed HD diagnostic (Huntington’s disease participants [HDPs])
were recruited in four Belgian hospitals. Participants were first
contacted by their general practitioner or neurologist, who explained the aims of the study. Then they were referred to the
principal investigator. All participants were over 18 years of age,
had a family history of HD, and completed a genetic blood test
assessing the HD’s cytosine–adenine– guanine (CAG) expansion.
HD is characterized by elongated CAG repeat on at least one allele
of the chromosome 4 on the Huntingtin gene (Roos, 2010). All
participants presented an expansion of at least 36 CAG repeats.
Among them, 18 were at preclinical stage (HDP⫺) and 20 were at
clinical stage (HDP⫹). The disease stage was assessed according
to Roos’s (2010) criteria. Among those with HDP⫺, 15 were at the
A2 stage (i.e., gene carrier, premanifest stage) and three were at
the A3 stage (i.e., transition phase, ongoing changes at behavioral
and motor levels). Among those with HDP⫹, 12 were at the B1
stage (i.e., Clinical Stage I, with initial neurological, cognitive, and
psychiatric symptoms, with chorea being the most prominent
symptom) and eight were at the B2 stage (i.e., Clinical Stage II,
with generalized motor disturbance and increased cognitive–
psychiatric symptoms). The mean illness duration among patients
with HDP⫹ was 7.04 years (SD ⫽ 5.57). The mean number of
CAG repeats of the longest allele was 41.8 (SD ⫽ 3.20) in HDP⫺
and 43.74 (SD ⫽ 3.89) in HDP⫹. Moreover, a clinical evaluation
of the psychological, social, and occupational abilities of the
patients was conducted by a neurologist through the Clinical
Global Impression scale (CGI; Guy, 1976), a widely used tool with
a scale ranging from 1 (normal) to 7 (among the most ill patients).
In HDP⫺, CGI scores were between 1 (normal) and 2 (borderline;
M ⫽ 1.20, SD ⫽ .41). In HDP⫹, CGI scores were between 3
(mildly ill) and 5 (markedly ill; M ⫽ 4.35, SD ⫽ .67). Patients
were matched for age, gender, and education with 38 control
participants (CPs). Two subgroups of CP were determined (CP⫺,
CP⫹), respectively matched with the HDP⫺ and HDP⫹ groups.
Groups’ characteristics appear in Table 1. Exclusion criteria for
both groups included major medical problems, neurological disease other than HD, and psychiatric disorder, as assessed through
the Mini International Neuropsychiatric Interview (Sheehan et al.,
1998). Education level was assessed according to the number of
years of education completed since starting primary school.
Materials and Measurements
Questionnaires. Validated self-completion questionnaires
were used to assess depression (the French version of the second
edition of the Beck Depression Inventory; Beck, Steer, & Brown,
1998) and trait-anxiety (State and Trait Anxiety Inventory; Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983).
Attentional task. The ANT was administered to determine
the efficiency of three independent attentional networks: alerting,
orienting, and executive control (Fan et al., 2002). Participants had
to determine as fast and accurately as possible the direction of a
central arrow (the target) by pressing the corresponding button
(left or right) on a mouse. These targets were preceded by a cue,
MAURAGE ET AL.
4
Table 1
Demographic and Psychopathological Measures for Clinical (HDP⫹) and Preclinical (HDP⫺) Huntington’s Disease Participants
and Matched Controls (CP⫹ and CP⫺, Respectively)
Huntington’s Disease Participants (HDP)
Variable
This document is copyrighted by the American Psychological Association or one of its allied publishers.
This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
Demographic measures
Age: M (SD)
Gender ratio (F/M)
Educational level (in years): M (SD)
Psychopathological measures: M (SD)
Beck Depression Inventory
Trait Anxiety Inventory
Control Participants (CP)
HDP⫹ (n ⫽ 20) HDP⫺ (n ⫽ 18) All HDP (n ⫽ 38) CP⫹ (n ⫽ 20) CP⫺ (n ⫽ 18) All CP (n ⫽ 38)
49.1 (11.3)
8/12
10.9 (3.6)
40.4 (14.3)
7/11
13.2 (2.7)
44.9 (13.4)
15/23
11.9 (3.3)
49.6 (15.7)
8/12
12.1 (2.8)
39.4 (15.0)
7/11
12.0 (4.2)
44.8 (16.0)
15/23
12.0 (3.5)
13.4 (9.1)
43.3 (10.4)
12.2 (8.9)
45.1 (11.3)
12.8 (8.9)
44.1 (10.7)
11.9 (6.4)
40.3 (8.5)
10.8 (6.1)
43.1 (8.8)
11.4 (6.2)
41.6 (8.7)
Note. F/M ⫽ female/male.
with four possible cue types (see Figure 1A): no cue, center cue (an
asterisk replacing the fixation cross), double cue (two asterisks,
respectively appearing above and below the fixation cross), or
spatial cue (an asterisk appearing above or below the fixation cross
and indicating the location of the upcoming target). Moreover,
flankers were located on each side of the target, with three possible
flanker types (see Figure 1B): two arrows in the same direction as
the target (congruent condition), two arrows in the opposite direction of the target (incongruent condition), or two lines (neutral
condition). Each trial was as follows (see Figure 1C): (a) a central
fixation cross (random duration, 400 – 600 ms); (b) a cue (100 ms);
(c) a central fixation cross (400 ms); (d) a target and its flankers,
appearing above or below the fixation cross (lasting until the
participant responded or for 1,700 ms); (e) a central fixation cross
(lasting for 3,500 ms minus the sum of the first fixation period’s
duration and the reaction time [RT)]). RT (ms) and accuracy (percentage of correct responses) were recorded for each trial.
The ANT comprised 288 trials, divided in three blocks of 96
trials each (with a short break between blocks). There were 48
possible trials, based on the combination of four cues (no cue,
center cue, double cue, spatial cue), three flankers (congruent,
incongruent, neutral), two directions of the target arrow (left,
right), and two localizations (upper or lower part of the screen).
Trials were presented in a random order, and each possible trial
was presented twice within a block. The task was programmed and
presented using E-Prime 2 Professional (Psychology Software
Tools, 2012).
Procedure
Figure 1. Description of the attention network test used to explore the
three attentional networks (alerting, orienting, executive conflict) in Huntington’s disease, presenting the four possible cues (Panel A), the six
possible targets (Panel B), and a trial example (Panel C; i.e., neutral trial
preceded by a double cue, the correct response being “right”). Adapted
from Fan, McCandliss, Sommer, Raz, and Posner (2002).
The task was completed individually in one 45-min session in a
quiet, dimly lit room. Participants were provided with full details
regarding the aims of the study and the procedure to be followed,
and they signed the written informed consent. Each participant was
then provided with the instructions on the computer screen. These
instructions were emphasized by the experimenter, and then a
training session consisting of 24 randomly selected trials began.
Finally, the experimenter recalled the instructions and answered
the remaining questions before starting the experiment. The distance between participants’ eyes and the screen was 50 cm, and the
target stimuli subtended a visual angle of about 4° in the horizontal
field. After the experimental task, participants filled in the questionnaires and were debriefed individually. This study was approved by the Ethical Committee of the Université catholique de
Louvain (Belgium) and conducted according to the Declaration of
Helsinki (World Medical Association, 2013). Participants received
compensation (25 euros) for their participation. This experiment
was part of a larger project investigating neurocognitive and emotional deficits in HD (e.g., Maurage et al., 2016).
ATTENTIONAL NETWORKS IN HUNTINGTON’S DISEASE
This document is copyrighted by the American Psychological Association or one of its allied publishers.
This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
Data Preparation and Analytic Plan
Power analysis. An a priori power analysis was conducted to
determine the appropriate total sample size for testing hypotheses
with the primary outcome variable. We expected, based on previous studies on cognition in preclinical and clinical HD (Finke et
al., 2007; Harrington et al., 2014; Peretti et al., 2010; Wolf et al.,
2011), a medium effect size of Cohen’s d ⫽ .50. Setting alpha at
.05, and power (1 ⫺ ) at .80 on a repeated-measures design, the
power analysis (GⴱPower 3.1.3; Faul, Erdfelder, Lang, & Buchner,
2007) indicated that a total sample size of 17 individuals per group
would yield adequate power, thus confirming that the chosen
design and sample size had enough statistical power to test our
hypothesis.
Statistical analyses. We addressed outliers and errors in the
experimental tasks as follows. First, trials with incorrect responses
were excluded (5.58% of trials). Second, RTs lower than 200 ms
or greater than 2,000 ms were removed from analyses (.007% of
the remaining trials). Third, RTs of more than 2 SDs below or
above each participant’s mean for each experimental condition
were excluded as outliers (.024% of the remaining trials). Data
analyses were performed following the approach pioneered by Fan
and his colleagues (Fan et al., 2002, 2009) and increasingly used
by others (e.g., Heeren et al., 2014; Moriya & Tanno, 2009;
Sommerfeldt et al., 2016; Tortella-Feliu et al., 2014). Because a
preliminary analysis showed no difference in RT or accuracy
according to the direction (left or right) and localization (upper or
lower) of the arrow, these trials were thus merged, leading to 24
trials for each of the 12 experimental conditions (four cues ⫻ three
flankers).
Clinical HD groups were older than preclinical ones due to the
progressive nature of HD-related disorders (see Table 1). Two
types of analyses were thus conducted to explore the differential
attentional impairment across the successive stages of the disease
while taking this age difference (known to influence attentional
processes; Deiber, Ibañez, Missonnier, Rodriguez, & Giannakopoulos, 2013; Mahoney, Verghese, Goldin, Lipton, & Holtzer,
2010) into account: (a) a direct comparison between HD subgroups
(i.e., preclinical HDP⫺ and clinical HDP⫹) with the inclusion of
age as a covariate and (b) a comparison between each HD group
(preclinical HDP⫺ and clinical HDP⫹) and its respective control
group (CP⫺ and CP⫹), matched for age, gender, and education.
First, for each subgroup comparison, general 2 ⫻ 4 ⫻ 3 analyses
of variance (ANOVAs) were performed separately for RT and
accuracy with Group (HDP⫺ vs. HDP⫹; HDP⫺ vs. CP⫺; HDP⫹
vs. CP⫹) as between-subjects variable and Cue (no cue, central
cue, double cue, spatial cue) and Flanker (congruent, incongruent,
neutral) as within-subject variables.
We then computed the alerting effect by subtracting the mean
(i.e., RT or accuracy score) for double-cue trials from the mean for
no-cue trials (no cue ⫺ double cue), the orienting effect by
subtracting the mean for spatial-cue trials from the mean result for
center-cue trials (center cue ⫺ spatial cue), and the executive
conflict effect by subtracting the mean for congruent trials
(summed across cue types) from the mean for incongruent trials
(Incongruent ⫺ Congruent). For both the alerting and orienting
effects, greater subtraction scores for RT (and lower for accuracy)
indicated greater efficiency. In contrast, greater subtraction scores
for RT (and lower for accuracy) on executive conflict indicated
5
increased difficulty with executive control of attention (Fan et al.,
2005). Consequently, a second general 2 ⫻ 3 ANOVA was performed separately for RT and accuracy with Group as betweensubjects variable and Attention Network (alerting, orienting, executive conflict) as within-subject variable.
For each ANOVA, significant main effects and interactions
were followed up by corrected post hoc independent-samples t
tests. Independent-samples t tests were computed to explore group
differences on control measures. Two-tailed Pearson’s correlations
were also performed to explore the links between experimental
results and psychopathological variables. Because our main focus
concerned the exploration of a potential deficit in HD, the Results
section focuses on group comparison and the overall effects for
each ANOVA (i.e., significant results not related to group differences) are reported in the online supplemental materials. Statistical
analyses were performed using the SPSS 19 software package.
Results
Group Equivalence
HDP⫺ versus HDP⫹: As shown in Table 1, no significant
difference was identified for gender, 2(1, 38) ⫽ .005, p ⫽ .999;
education, t(36) ⫽ 1.63, p ⫽ .118; depression, t(36) ⫽ .41, p ⫽
.684; or anxiety, t(36) ⫽ .53, p ⫽ .599. However, age was related
to a significant group difference, t(36) ⫽ 2.09, p ⫽ .043, HDP⫹
being significantly older than HDP⫺. Age was thus included as a
covariate in the following HDP⫺ versus HDP⫹ comparisons.
HDP⫺ versus CP⫺: No significant difference was observed for
age, t(34) ⫽ .21, p ⫽ .835; gender, 2(1, 38) ⬍ .001, p ⫽ .99;
education, t(34) ⫽ .99, p ⫽ .329; depression, t(34) ⫽ .52, p ⫽
.606; or anxiety, t(34) ⫽ .61, p ⫽ .546.
HDP⫹ versus CP⫹: No significant difference was described
for age, t(38) ⫽ .12, p ⫽ .905; gender, 2(1, 38) ⫽ 0, p ⫽ 1;
education, t(38) ⫽ 1.13, p ⫽ .266; depression, t(38) ⫽ .58, p ⫽
.565; or anxiety, t(38) ⫽ .98, p ⫽ .333.
General Analysis
A 2 (groups: HDP⫺ and HDP⫹/HDP⫺ and CP⫺/HDP⫹ and
CP⫹, respectively for the three subgroup comparison) ⫻ 4 (cues:
no cue, central cue, double cue, spatial cue) ⫻ 3 (flankers: congruent, incongruent, neutral) ANOVA was performed separately
for RT and accuracy in each subgroup comparison. The means and
standard deviations for each group in each experimental condition
are presented in Table 2.
Reaction Times
HDP⫺ versus HDP⫹: A main group effect was identified, F(1,
35) ⫽ 17.82, p ⬍ .001, p2 ⫽ .38, because HDP⫹ presented longer
RTs than did HDP⫺. A Group ⫻ Flanker interaction was also
detected, F(2, 70) ⫽ 4.26, p ⫽ .018, p2 ⫽ .11. A between-groups
post hoc comparison showed that HDP⫹ presented longer RTs
than did HDP⫺ for congruent, t(36) ⫽ 4.13, p ⬍ .001; incongruent, t(36) ⫽ 5.34, p ⬍ .001; and neutral, t(36) ⫽ 4.89, p ⬍ .001,
flankers. However, this group difference was significantly stronger
for incongruent than for congruent, t(17) ⫽ 2.67, p ⫽ .016, and
neutral, t(17) ⫽ 2.54, p ⫽ .021, flankers. Neither the Group ⫻
MAURAGE ET AL.
6
Table 2
Mean (and Standard Deviation) Reaction Time and Accuracy Measures for Clinical (HDP⫹) and Preclinical (HDP⫺) Huntington’s
Disease Participants and Matched Controls (CP⫹ and CP⫺, Respectively)
Huntington’s Disease Participants (HDP)
This document is copyrighted by the American Psychological Association or one of its allied publishers.
This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
Variable
Congruent condition
Reaction time (ms)
No cue
Center cue
Double cue
Spatial cue
Accuracy (%)
No cue
Center cue
Double cue
Spatial cue
Incongruent condition
Reaction time (ms)
No cue
Center cue
Double cue
Spatial cue
Accuracy (%)
No cue
Center cue
Double cue
Spatial cue
Neutral condition
Reaction time (ms)
No cue
Center cue
Double cue
Spatial cue
Accuracy (%)
No cue
Center cue
Double cue
Spatial cue
Control Participants (CP)
HDP⫹ (n ⫽ 20)
HDP⫺ (n ⫽ 18)
All HDP (n ⫽ 38)
CP⫹ (n ⫽ 20)
CP⫺ (n ⫽ 18)
All CP (n ⫽ 38)
850 (161)
831 (156)
809 (154)
785 (140)
663 (157)
624 (154)
612 (138)
592 (136)
761 (183)
733 (185)
715 (176)
693 (168)
612 (111)
587 (114)
569 (106)
547 (107)
608 (113)
581 (126)
571 (111)
553 (115)
610 (110)
584 (118)
570 (107)
550 (109)
86.25 (15.60)
90.62 (12.67)
91.87 (12.13)
90.21 (13.40)
97.69 (4.78)
97.68 (4.34)
98.15 (4.10)
98.61 (3.50)
91.67 (13.00)
93.97 (10.19)
94.85 (9.66)
94.19 (10.77)
99.17 (2.18)
99.58 (1.28)
99.79 (.93)
99.79 (.93)
99.54 (1.35)
99.77 (.98)
99.77 (.98)
99.31 (2.14)
99.34 (1.82)
99.67 (1.14)
99.78 (.94)
99.56 (1.62)
754 (151)
742 (149)
735 (157)
688 (143)
902 (206)
882 (212)
875 (215)
835 (220)
703 (134)
708 (140)
713 (128)
642 (131)
714 (133)
717 (150)
708 (157)
662 (155)
708 (132)
712 (143)
710 (140)
651 (141)
71.25 (27.87)
72.08 (28.58)
74.38 (26.98)
75.21 (27.85)
92.59 (12.50)
93.77 (10.52)
96.53 (9.07)
95.37 (7.13)
81.36 (24.23)
82.36 (24.31)
84.87 (23.18)
84.76 (22.93)
95.21 (5.28)
95.42 (6.18)
96.87 (3.79)
97.50 (3.42)
97.92 (2.58)
95.37 (7.94)
96.06 (6.31)
96.53 (4.57)
96.49 (4.39)
95.39 (6.97)
96.49 (5.08)
97.04 (3.98)
834 (131)
834 (129)
814 (109)
803 (137)
652 (139)
620 (139)
606 (131)
583 (157)
748 (162)
733 (171)
715 (158)
699 (183)
610 (94)
582 (109)
584 (104)
551 (105)
604 (114)
580 (123)
566 (116)
551 (114)
607 (103)
581 (114)
575 (108)
551 (108)
89.58 (13.62)
89.58 (13.00)
87.50 (15.71)
90.00 (12.78)
99.31 (2.14)
98.15 (4.79)
98.38 (4.08)
98.38 (3.54)
94.19 (11.03)
93.64 (10.78)
92.65 (12.83)
93.97 (10.37)
98.33 (2.10)
99.17 (1.71)
99.58 (1.28)
99.17 (2.18)
98.61 (2.02)
99.77 (.98)
99.31 (1.60)
100 (.00)
98.46 (2.04)
99.45 (1.43)
99.45 (1.43)
99.56 (1.62)
1,034 (153)
1,008 (180)
1,001 (181)
967 (192)
Cue, F(3, 105) ⫽ .27, p ⫽ .847, nor the Group ⫻ Cue ⫻ Flanker,
F(6, 210) ⫽ .99, p ⫽ .433, interactions were significant.
HDP⫺ versus CP⫺: No main group effect was observed, F(1,
34) ⫽ .74, p ⫽ .396, nor was there any interaction with cue, F(3,
102) ⫽ .96, p ⫽ .415, or flanker, F(2, 68) ⫽ .61, p ⫽ .546, or a
Group ⫻ Cue ⫻ Flanker interaction, F(6, 204) ⫽ .08, p ⫽ .998.
HDP⫹ versus CP⫹: A main group effect was described, F(1,
38) ⫽ 43.88, p ⬍ .001, p2 ⫽ .54, because HDP⫹ presented longer
RTs than did CP⫹. A Group ⫻ Flanker interaction was also
detected, F(2, 76) ⫽ 7.01, p ⫽ .002, p2 ⫽ .16. A between-groups
post hoc comparison showed that HDP⫹ presented longer RTs
than did CP⫹ for congruent, t(38) ⫽ 5.68, p ⬍ .001; incongruent,
t(38) ⫽ 6.81, p ⬍ .001; and neutral, t(38) ⫽ 6.67, p ⬍ .001,
flankers. However, this group difference was significantly stronger
for incongruent than for congruent, t(19) ⫽ 2.81, p ⫽ .011, and
neutral, t(19) ⫽ 2.93, p ⫽ .008, flankers. No Group ⫻ Cue, F(3,
114) ⫽ .97, p ⫽ .409, or Group ⫻ Cue ⫻ Flanker, F(6, 228) ⫽
1.76, p ⫽ .108, interactions were detected.
Accuracy
HDP⫺ versus HDP⫹: The analysis revealed a main group
effect, F(1, 35) ⫽ 10.28, p ⫽ .002, p2 ⫽ .23, because HDP⫹
presented lower accuracy scores than did HDP⫺. A Group ⫻
Flanker interaction was also observed, F(2, 70) ⫽ 8.65, p ⬍ .001,
p2 ⫽ .20. A between-groups post hoc comparison showed that
HDP⫹ presented lower accuracy than did HDP⫺ for congruent,
t(36) ⫽ 2.65, p ⫽ .012; incongruent, t(36) ⫽ 3.18, p ⫽ .003; and
neutral, t(36) ⫽ 3.03, p ⫽ .005, flankers. However, this group
difference was significantly stronger for incongruent than for congruent, t(17) ⫽ 3.32, p ⫽ .004, and neutral, t(17) ⫽ 2.95, p ⫽ .009,
flankers. No Group ⫻ Cue, F(3, 105) ⫽ 1.09, p ⫽ .357, or
Group ⫻ Cue ⫻ Flanker, F(6, 210) ⫽ .57, p ⫽ .754, interactions
were identified.
HDP⫺ versus CP⫺: No main group effect was described, F(1,
34) ⫽ 1.27, p ⫽ .268, nor was there any interaction with cue, F(3,
102) ⫽ 1.26, p ⫽ .292, or flanker, F(2, 68) ⫽ .27, p ⫽ .764, or a
Group ⫻ Cue ⫻ Flanker interaction, F(6, 204) ⫽ 1.92, p ⫽ .079.
HDP⫹ versus CP⫹: The analysis revealed a main group effect,
F(1, 38) ⫽ 13.88, p ⬍ .001, p2 ⫽ .27, because HDP⫹ presented
lower accuracy scores than did CP⫹. A Group ⫻ Flanker interaction was also observed, F(2, 76) ⫽ 11.58, p ⬍ .001, p2 ⫽ .23.
A between-groups post hoc comparison showed that HDP⫹ presented lower accuracy than did CP⫹ for congruent, t(38) ⫽ 3.49,
p ⫽ .002; incongruent, t(38) ⫽ 3.99, p ⬍ .001; and neutral, t(38) ⫽
ATTENTIONAL NETWORKS IN HUNTINGTON’S DISEASE
3.64, p ⫽ .002, flankers, but this group difference was significantly
stronger for incongruent than for congruent, t(19) ⫽ 3.73, p ⫽
.001, and neutral, t(19) ⫽ 3.61, p ⫽ .002, flankers. No Group ⫻
Cue, F(3, 114) ⫽ .79, p ⫽ .502, or Group ⫻ Cue ⫻ Flanker, F(6,
228) ⫽ 1.24, p ⫽ .287, interactions were observed.
pathological factors (i.e., depression and anxiety measures) and experimental results (i.e., results for accuracy
and RT in the three attentional networks). No significant
correlation was observed (all ps ⬎ .05).
2.
Link in the HD groups between disease intensity indices
(CGI score, number of CAG repeats, disease duration,
and disease stage) and experimental results: No significant correlation was observed for the number of CAG
repeats and for disease duration (p ⬎ .05 for every
correlation). However, for the CGI score as well as for
disease stage, no significant correlations were observed
for alerting and orienting (all ps ⬎ .05), but the extent of
executive control impairment was significantly correlated with the CGI score (RT: r ⫽ .37, p ⫽ .011;
accuracy: r ⫽ .53, p ⬍ .001) and with disease stage (RT:
r ⫽ .29, p ⫽ .038; accuracy: r ⫽ .23, p ⫽ .041).
3.
Influence of fatigue factor: Because fatigue might differently affect groups and influence the results, experimental data were divided in three successive blocks, that is,
Block 1 (first 96 trials of the task), Block 2 (Trials
97–192), and Block 3 (Trials 193–288), and the ANOVAs related to attentional networks for each group
comparison were recomputed with the inclusion of
block as a three-level within-subject variable. As fully
reported in the online supplemental materials, this
analysis replicated the results observed in the initial
ANOVA, and no significant main block effect or interaction with Group and Attentional Networks were
observed on the results, showing that fatigue cannot
account for the results.
This document is copyrighted by the American Psychological Association or one of its allied publishers.
This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
Attentional Networks Analyses
A 2 (groups: HDP⫺ and HDP⫹/HDP⫺ and CP⫺/HDP⫹ and
CP⫹, respectively for the three subgroup comparison) ⫻ 3 (attentional networks: alerting, orienting, executive conflict) ANOVA was
performed separately for RT and accuracy in each subgroup comparison. These results are illustrated in Figure 2.
Reaction times. HDP⫺ versus HDP⫹: No main group effect
was observed, F(1, 35) ⫽ 2.13, p ⫽ .153. However, a Group ⫻
Attentional Networks interaction emerged, F(2, 70) ⫽ 5.03, p ⫽
.009, p2 ⫽ .13. A between-groups post hoc comparison showed
that, compared to HDP⫺, HDP⫹ presented higher RT subtraction
scores for executive conflict, t(36) ⫽ 2.76, p ⫽ .009, but not for
alerting, t(36) ⫽ .87, p ⫽ .390, or orienting, t(36) ⫽ .24, p ⫽ .811.
HDP⫺ versus CP⫺: No main group effect was described, F(1,
34) ⬍ .001, p ⫽ .99, nor was there any Group ⫻ Attentional
Networks interaction, F(2, 68) ⫽ 1.03, p ⫽ .362.
HDP⫹ versus CP⫹: The analysis revealed a main group effect,
F(1, 38) ⫽ 5.05, p ⫽ .03, p2 ⫽ .12, because HDP⫹ presented
higher RT subtraction scores than did CP⫹. A Group ⫻ Attentional Networks interaction was also identified, F(2, 76) ⫽ 6.25,
p ⫽ .003, p2 ⫽ .14. A between-groups post hoc comparison
showed that, compared to CP⫹, HDP⫹ were impaired for executive conflict, t(38) ⫽ 2.81, p ⫽ .011, but not for alerting, t(38) ⫽
.54, p ⫽ .592, or orienting, t(38) ⫽ .59, p ⫽ .559.
Accuracy. HDP⫺ versus HDP⫹: A main group effect
emerged, F(1, 35) ⫽ 8.98, p ⫽ .005, p2 ⫽ .21, because HDP⫹
presented higher accuracy subtraction scores than did HDP⫺. A
Group ⫻ Attentional Networks interaction was also identified,
F(2, 70) ⫽ 8.38, p ⫽ .001, p2 ⫽ .19. A between-groups post hoc
comparison showed that, compared to HDP⫺, HDP⫹ were impaired for executive conflict, t(36) ⫽ 3.11, p ⫽ .004, but not for
alerting, t(36) ⫽ .88, p ⫽ .385, or orienting, t(36) ⫽ .09, p ⫽ .929.
HDP⫺ versus CP⫺: The analysis did not reveal a main group
effect, F(1, 34) ⫽ 1.13, p ⫽ .295, nor was there any Group ⫻
Attentional Networks interaction, F(2, 68) ⫽ .35, p ⫽ .706.
HDP⫹ versus CP⫹: A main group effect was observed, F(1,
38) ⫽ 11.16, p ⫽ .002, p2 ⫽ .23, because HDP⫹ presented higher
accuracy subtraction scores than did CP⫹. A Group ⫻ Attentional
Networks interaction was also revealed, F(2, 76) ⫽ 9.48, p ⬍ .001,
p2 ⫽ .20. A between-groups post hoc comparison showed that,
compared to CP⫹, HDP⫹ were impaired for executive conflict,
t(38) ⫽ 3.73, p ⬍ .001, but not for alerting, t(38) ⫽ .85, p ⫽ .401,
or orienting, t(38) ⫽ .22, p ⫽ .827.
Complementary Analyses
Complementary analyses were conducted to explore the influence of confounding factors (i.e., psychopathological measures,
HD characteristics, and fatigue) on the experimental results:
1.
Influence of psychopathological factors: Pearson’s correlations were conducted in all groups among psycho-
7
Discussion
In this study, we proposed the first joint exploration of the three
attentional networks in preclinical and clinical HD. We found that
clinical HD does not lead to a global attentional deficit but rather
to a specific impairment for executive control network, with preserved alerting and orienting networks. Clinical HD patients first
showed globally increased RTs and reduced accuracy compared to
preclinical HD patients and matched controls, indexing a general
cognitive and visuomotor processing speed deficit, which is consistent with earlier results (Aron et al., 2003; Say et al., 2011). Of
critical importance, the executive attentional subcomponent was
significantly impaired in clinical HD, because these patients exhibited longer RTs for task-irrelevant stimuli than did preclinical
patients and controls. Because this measure specifically reflects the
RT delay provoked by the presence of nonpertinent flankers (in
incongruent trials) compared to pertinent ones (in congruent trials),
this indicates that those with clinical HD have difficulties to
resolve the conflict between task-relevant information (i.e., the
central arrow to be processed) and interfering distractors (i.e., the
incongruent and irrelevant flankers). This RT delay is also present
among controls, as observed earlier (Fan et al., 2009), but is
significantly increased in clinical HD. Attentional deficits in clinical HD are thus related to a decreased ability to distinguish
task-relevant and task-irrelevant stimuli, and to solve the conflict
between these contradictory cues. This proposal is further reinforced by accuracy results showing reduced performance in clin-
MAURAGE ET AL.
This document is copyrighted by the American Psychological Association or one of its allied publishers.
This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
8
Figure 2. Clinical Huntington’s disease participants (HDP⫹) and preclinical Huntington’s disease participants
(HDP⫺; Panel A), preclinical Huntington’s disease participants (HDP⫺) and matched control participants
(CP⫺; Panel B), and clinical Huntington’s disease participants (HDP⫹) and matched control participants (CP⫹;
Panel C) performance related to the indices computed on reaction times for the three attentional networks
(alerting, orienting, executive conflict). Error bars represent standard errors of the mean. ⴱ p ⬍ .05.
This document is copyrighted by the American Psychological Association or one of its allied publishers.
This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
ATTENTIONAL NETWORKS IN HUNTINGTON’S DISEASE
ical HD for incongruent compared to congruent trials, which is in
line with RT results and indexes a global deficit of the executive
conflict network. Because HDP⫹ and CP⫹ groups were matched
for demographical factors and because age was included as a
covariate in the HD groups’ comparison, this impairment cannot
be explained by differences in these variables. Moreover, the
control of comorbid psychopathological states and their absence of
link with experimental results suggest that the deficit cannot be
attributed to comorbid depressive or anxious symptomatology
among HD patients.
It is important to note that this executive control deficit is not
part of broader visuomotor or attentional impairments, which
would encompass various subcomponents of attention. Indeed,
alerting and orienting networks are preserved in clinical HD. These
patients are thus still able to use their alerting network to increase
their alertness or vigilance after a cue and to get ready for the
processing of upcoming stimuli. Moreover, they have an intact
ability to mobilize their orienting network following a spatial cue
to move their attentional focus toward relevant information by
successively disengaging attentional resources from a previous
target and shifting them toward a new target. This differential
deficit between preserved alerting or orienting and impaired executive conflict networks is not the mere consequence of a higher
complexity for the executive control network, because earlier
studies have shown a reverse pattern of deficits, notably in movement disorders. Indeed, Wilson’s and Parkinson’s diseases are
related with preserved executive control network but impaired
alerting (Han et al., 2014) or orienting (Zhou et al., 2012) networks, respectively, implying that the various pathologies leading
to movement disorders are characterized by differential attentional
deficits.
The present results are in line with previous ones showing
impairments for cognitive subcomponents related to the executive
conflict network, like attentional inhibitory control (Henderson et
al., 2011), executive managing of the attentional resources (Peretti
et al., 2008, 2010), or selective attention in clinical HD (GeorgiouKaristianis et al., 2012). Concerning alerting and orienting networks, previous results had led to mixed conclusions, some suggesting a preservation of these processes (Beste et al., 2008) and
others showing impaired alertness (Duff et al., 2010; Hart et al.,
2015) or orienting (Couette et al., 2008). However, the use of
multidetermined tasks in these earlier studies cannot rule out the
possibility that the observed deficits are related to the involvement
of other attentional subcomponents (and potentially of executive
control) in the task. The present study thus clarifies this debate by
showing that alerting and orienting networks are preserved in
clinical HD when a more specific measure is proposed.
Another central result of this study is the dissimilarity observed
between preclinical and clinical HD, because attentional processes
are preserved in preclinical HD, in line with most previous results
(Hart et al., 2012, 2015; Lemiere et al., 2004; Malejko et al., 2014).
However, because reduced brain activities during attentional tasks
have been suggested in preclinical HD (Wolf et al., 2011), subtle
attentional impairments might already be present at the cerebral
level in preclinical HD while remaining undetectable by behavioral measures. The current study nevertheless clearly shows that
the impairment observed for executive conflict in clinical HD is
not related to the carrying of HD’s gene but is rather the consequence of the neurodegenerative evolution observed at the clinical
9
stage, as further illustrated by the correlational analyses showing
significant links between disease severity (i.e., CGI score and
disease stage) and executive control deficits. By distinguishing
preclinical and clinical patients, our results support the proposal
that attentional processes might constitute a biomarker of disease
stage in HD (Dumas et al., 2013), but future studies on broader
samples are needed to determine whether the ANT can be used as
an efficient complementary tool to determine disease stage.
Several issues also require further examination in follow-up
research. First, our experimental design did not include other
neuropsychological measures, and no data were collected regarding cognitive and executive functions in HD patients. The links
between executive control and other executive deficits repeatedly
reported in HD (Beglinger et al., 2010; Beste et al., 2008) should
be further explored to clearly determine the interactions between
the executive control impairment reported here and the other
cognitive functions impaired in clinical HD patients. Second,
although it can be postulated that the attentional impairments
observed here in clinical HD are related to the brain changes
appearing during the course of the disease, no cerebral measures
were performed in the present study, and future neuroimaging
works are thus needed to determine the brain correlates of the
executive control deficit, particularly regarding thalami, cingulate
cortex, and superior-inferior frontal gyri, which are the key regions
for executive control (Fan et al., 2005; Visintin et al., 2015).
Eventually, although the preservation of alerting and orienting
abilities in clinical HD excludes the hypothesis that executive
control impairments might be the mere consequence of a far more
global cognitive deficit, no measure of global intellectual functioning was performed, and it can thus not be excluded that the
deficit observed for executive control might partly rely on more
general cognitive disabilities in clinical HD.
Despite these limitations, the present results bare critical insights at both fundamental and clinical levels. At the fundamental
level, they reinforce the experimental validity of the ANT theoretical model (Fan et al., 2002) by indicating that the three networks are independent because they can be differentially impaired.
Our results, together with earlier ones, even constitute a convincing confirmation of this three-networks model in the field of
movement disorders, because alerting, orienting, and executive
conflict networks are respectively impaired in Wilson’s (Han et al.,
2014), Parkinson’s (Zhou et al., 2012), and Huntington’s diseases,
each disease being related with a preservation of the two other
networks (i.e., orienting and executive control in Wilson’s disease,
alerting and executive control in Parkinson’s disease, alerting and
orienting in HD). Beyond the ANT model (Petersen & Posner,
2012; Posner & Petersen, 1990), our results also bring some
insights regarding the theoretical framework proposed by Stuss,
Shallice, Alexander, and Picton (1995). According to this framework, the frontal lobe constitutes the chief structure of complex
attentional processes. Indeed, this model (Stuss & Alexander,
2007; Stuss et al., 2005) is organized around an “anterior attentional system,” relying on several frontal regions, which would
manage three main attention-related subcomponents, namely energizing (i.e., initiating and sustaining attentional resources mobilization, relying on the superior medial frontal gyrus), task setting
(i.e., establishing a stimulus–response link by associative learning,
relying on the left lateral frontal gyrus), and monitoring (i.e.,
checking task accomplishment over time and ensuring its correct
This document is copyrighted by the American Psychological Association or one of its allied publishers.
This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
10
MAURAGE ET AL.
execution, relying on the right lateral frontal gyrus). Although the
present experimental design did not allow for exploring the brain
correlates of attentional subcomponents, the massive deficit observed here in clinical HD for executive conflict abilities, known
to rely on frontal networks, supports the proposal formulated by
Stuss and colleagues that frontal cortex integrity is essential for
efficient high-level attentional abilities and suggests that attentional deficits in HD might directly result from the frontal dysfunctions reported in this population (Eidelberg & Surmeier, 2011;
Wolf & Klöppel, 2013). Conversely, the preservation of alerting
and orienting networks in clinical HD also supports the hypothesis
that lower level attentional subcomponents would involve regions
other than the frontal ones (e.g., anterior cingulate cortex; Shallice,
Stuss, Alexander, Picton, & Derkzen, 2008; Stuss & Alexander,
2007), which might be less damaged in clinical HD. A complementary explanation of the present results could be that, because
alerting is centrally involved in the mobilization and sustaining
of attentional resources, this network might be considered as
part of the energizing system described in Stuss’s (2005) theory. In this perspective, it can be hypothesized that the frontal
areas involved in the alerting or energizing system (and particularly the superior medial frontal gyrus) might be less damaged
in HD than are those underlying the executive control network
and task setting or monitoring systems. Neuroimaging results
have supported this proposal by showing preserved medial
frontal gyrus structure in HD (Nopoulos et al., 2010), with
conversely strongly impaired lateral frontal regions, even at the
early stages of the disease (e.g., Matsui et al., 2014). However,
neuroimaging studies further exploring the differential anatomical and functional deficits across the subcomponents of the
frontal lobe should be conducted in HD to offer a more direct
exploration of these proposals.
At the clinical level, our results underline the importance of
cognitive deficits in clinical HD. In view of their role in daily life
and treatment compliance (Beglinger et al., 2012; Paulsen & Long,
2014), rehabilitating attentional impairments might alleviate the
disease’s burden for patients and relatives. Earlier rehabilitation
programs in HD were based on global attentional rehabilitation
(Piira et al., 2014; Veenhuizen et al., 2011; Zinzi et al., 2007), but
the present study makes the case for focusing these programs on
the impaired attentional subcomponent (i.e., executive conflict), in
line with what has been done in other populations (Serino et al.,
2007; Thimm, Fink, Küst, Karbe, & Sturm, 2006). Moreover,
because executive control mostly relies on frontal gyri, neuromodulation (up to now used only for motor cortex stimulation in
HD; Ljubisavljevic, Ismail, & Filipovic, 2013; Medina & Túnez,
2010) could efficiently increase frontal activation and improve
executive control (Brunoni & Vanderhasselt, 2014).
In conclusion, this first exploration of attentional networks in
HD using the ANT allowed us to identify a differential deficit
between impaired executive control and preserved alerting and
orienting networks in clinical HD. This constitutes a significant
step toward the precise identification of cognitive deficits related
to the successive stages of the disease. Moreover, the present
results offer a sound basis for the development of specific rehabilitation programs focusing on impaired attentional subcomponents.
References
Aron, A. R., Watkins, L., Sahakian, B. J., Monsell, S., Barker, R. A., &
Robbins, T. W. (2003). Task-set switching deficits in early-stage Huntington’s disease: Implications for basal ganglia function. Journal of
Cognitive Neuroscience, 15, 629 – 642. http://dx.doi.org/10.1162/jocn
.2003.15.5.629
Bachoud-Lévi, A.-C., Rémy, P., Nguyen, J.-P., Brugières, P., Lefaucheur,
J. P., Bourdet, C., . . . Peschanski, M. (2000). Motor and cognitive
improvements in patients with Huntington’s disease after neural transplantation. Lancet, 356, 1975–1979. http://dx.doi.org/10.1016/S01406736(00)03310-9
Beck, A. T., Steer, R. A., & Brown, G. K. (1998). Beck Depression
Inventory manuel (2nd ed.) [Beck Depression Inventory manual (2nd
ed.)]. Paris, France: Editions du Centre de Psychologie Appliquée.
Beglinger, L. J., Duff, K., Allison, J., Theriault, D., O’Rourke, J. J.,
Leserman, A., & Paulsen, J. S. (2010). Cognitive change in patients with
Huntington disease on the Repeatable Battery for the Assessment of
Neuropsychological Status. Journal of Clinical and Experimental Neuropsychology, 32, 573–578. http://dx.doi.org/10.1080/13803390
903313564
Beglinger, L. J., Prest, L., Mills, J. A., Paulsen, J. S., Smith, M. M.,
Gonzalez-Alegre, P., . . . Uc, E. Y. (2012). Clinical predictors of driving
status in Huntington’s disease. Movement Disorders, 27, 1146 –1152.
http://dx.doi.org/10.1002/mds.25101
Beste, C., Saft, C., Andrich, J., Gold, R., & Falkenstein, M. (2008).
Stimulus-response compatibility in Huntington’s disease: A cognitiveneurophysiological analysis. Journal of Neurophysiology, 99, 1213–
1223. http://dx.doi.org/10.1152/jn.01152.2007
Brandt, J., Inscore, A. B., Ward, J., Shpritz, B., Rosenblatt, A., Margolis,
R. L., & Ross, C. A. (2008). Neuropsychological deficits in Huntington’s disease gene carriers and correlates of early “conversion.” Journal
of Neuropsychiatry and Clinical Neurosciences, 20, 466 – 472. http://dx
.doi.org/10.1176/jnp.2008.20.4.466
Brunoni, A. R., & Vanderhasselt, M. A. (2014). Working memory improvement with non-invasive brain stimulation of the dorsolateral prefrontal cortex: A systematic review and meta-analysis. Brain and Cognition, 86, 1–9. http://dx.doi.org/10.1016/j.bandc.2014.01.008
Bublak, P., Redel, P., & Finke, K. (2006). Spatial and non-spatial attention
deficits in neurodegenerative diseases: Assessment based on Bundesen’s
theory of visual attention (TVA). Restorative Neurology and Neuroscience, 24, 287–301.
Couette, M., Bachoud-Levi, A. C., Brugieres, P., Sieroff, E., & Bartolomeo, P. (2008). Orienting of spatial attention in Huntington’s Disease.
Neuropsychologia, 46, 1391–1400. http://dx.doi.org/10.1016/j
.neuropsychologia.2007.12.017
Deiber, M. P., Ibañez, V., Missonnier, P., Rodriguez, C., & Giannakopoulos, P. (2013). Age-associated modulations of cerebral oscillatory patterns related to attention control. NeuroImage, 82, 531–546. http://dx
.doi.org/10.1016/j.neuroimage.2013.06.037
Duff, K., Paulsen, J., Mills, J., Beglinger, L. J., Moser, D. J., Smith, M. M.,
. . . the PREDICT-HD Investigators and Coordinators of the Huntington
Study Group. (2010). Mild cognitive impairment in prediagnosed Huntington disease. Neurology, 75, 500 –507. http://dx.doi.org/10.1212/
WNL.0b013e3181eccfa2
Dumas, E. M., van den Bogaard, S. J., Middelkoop, H. A., & Roos, R. A.
(2013). A review of cognition in Huntington’s disease. Frontiers in
Bioscience, S5, 1–18. http://dx.doi.org/10.2741/S355
Eidelberg, D., & Surmeier, D. J. (2011). Brain networks in Huntington
disease. Journal of Clinical Investigation, 121, 484 – 492. http://dx.doi
.org/10.1172/JCI45646
Fan, J., Gu, X., Guise, K. G., Liu, X., Fossella, J., Wang, H., & Posner,
M. I. (2009). Testing the behavioral interaction and integration of
attentional networks. Brain and Cognition, 70, 209 –220. http://dx.doi
.org/10.1016/j.bandc.2009.02.002
This document is copyrighted by the American Psychological Association or one of its allied publishers.
This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
ATTENTIONAL NETWORKS IN HUNTINGTON’S DISEASE
Fan, J., McCandliss, B. D., Fossella, J., Flombaum, J. I., & Posner, M. I.
(2005). The activation of attentional networks. NeuroImage, 26, 471–
479. http://dx.doi.org/10.1016/j.neuroimage.2005.02.004
Fan, J., McCandliss, B. D., Sommer, T., Raz, A., & Posner, M. I. (2002).
Testing the efficiency and independence of attentional networks. Journal
of Cognitive Neuroscience, 14, 340 –347. http://dx.doi.org/10.1162/
089892902317361886
Faul, F., Erdfelder, E., Lang, A. G., & Buchner, A. (2007). GⴱPower 3: A
flexible statistical power analysis program for the social, behavioral, and
biomedical sciences. Behavior Research Methods, 39, 175–191. http://
dx.doi.org/10.3758/BF03193146
Fernández, P. J., Campoy, G., García Santos, J. M., Antequera, M. M.,
García-Sevilla, J., Castillo, A., . . . Fuentes, L. J. (2011). Is there a
specific pattern of attention deficit in mild cognitive impairment with
subcortical vascular features? Evidence from the attention network test.
Dementia and Geriatric Cognitive Disorders, 31, 268 –275. http://dx.doi
.org/10.1159/000327165
Fernandez-Duque, D., & Black, S. E. (2006). Attentional networks in
normal aging and Alzheimer’s disease. Neuropsychology, 20, 133–143.
http://dx.doi.org/10.1037/0894-4105.20.2.133
Finke, K., Schneider, W. X., Redel, P., Dose, M., Kerkhoff, G., Müller,
H. J., & Bublak, P. (2007). The capacity of attention and simultaneous
perception of objects: A group study of Huntington’s disease patients.
Neuropsychologia, 45, 3272–3284. http://dx.doi.org/10.1016/j
.neuropsychologia.2007.06.006
Fusco, F. R., Chen, Q., Lamoreaux, W. J., Figueredo-Cardenas, G., Jiao,
Y., Coffman, J. A., . . . Reiner, A. (1999). Cellular localization of
huntingtin in striatal and cortical neurons in rats: Lack of correlation
with neuronal vulnerability in Huntington’s disease. Journal of Neuroscience, 19, 1189 –1202.
Georgiou, N., Bradshaw, J. L., Phillips, J. G., & Chiu, E. (1996). The effect
of Huntington’s disease and Gilles de la Tourette’s syndrome on the
ability to hold and shift attention. Neuropsychologia, 34, 843– 851.
http://dx.doi.org/10.1016/0028-3932(95)00170-0
Georgiou-Karistianis, N., Farrow, M., Wilson-Ching, M., Churchyard, A.,
Bradshaw, J. L., & Sheppard, D. M. (2012). Deficits in selective attention in symptomatic Huntington disease: Assessment using an attentional blink paradigm. Cognitive and Behavioral Neurology, 25, 1– 6.
http://dx.doi.org/10.1097/WNN.0b013e318248c503
Guy, W. (1976). ECDEU assessment manual for psychopharmacology (1st
ed.). Rockville, MD: U. S. Department of Health, Education, and Welfare.
Han, Y., Zhang, F., Tian, Y., Hu, P., Li, B., & Wang, K. (2014). Selective
impairment of attentional networks of alerting in Wilson’s disease. PLoS
ONE, 9, e100454. http://dx.doi.org/10.1371/journal.pone.0100454
Harrington, D. L., Liu, D., Smith, M. M., Mills, J. A., Long, J. D.,
Aylward, E. H., & Paulsen, J. S. (2014). Neuroanatomical correlates of
cognitive functioning in prodromal Huntington disease. Brain and Behavior, 4, 29 – 40. http://dx.doi.org/10.1002/brb3.185
Hart, E. P., Dumas, E. M., Reijntjes, R. H. A. M., van der Hiele, K., van
den Bogaard, S. J. A., Middelkoop, H. A., . . . van Dijk, J. G. (2012).
Deficient sustained attention to response task and P300 characteristics in
early Huntington’s disease. Journal of Neurology, 259, 1191–1198.
http://dx.doi.org/10.1007/s00415-011-6334-0
Hart, E. P., Dumas, E. M., van Zwet, E. W., van der Hiele, K., Jurgens,
C. K., Middelkoop, H. A., . . . Roos, R. A. (2015). Longitudinal
pilot-study of sustained attention to response task and P300 in manifest
and pre-manifest Huntington’s disease. Journal of Neuropsychology, 9,
10 –20. http://dx.doi.org/10.1111/jnp.12031
Heeren, A., Maurage, P., Perrot, H., De Volder, A., Renier, L., Araneda,
R., . . . Philippot, P. (2014). Tinnitus specifically alters the top-down
executive control sub-component of attention: Evidence from the attention network task. Behavioural Brain Research, 269, 147–154. http://dx
.doi.org/10.1016/j.bbr.2014.04.043
11
Heeren, A., Maurage, P., & Philippot, P. (2015). Revisiting attentional
processing of non-emotional cues in social anxiety: A specific impairment for the orienting network of attention. Psychiatry Research, 228,
136 –142. http://dx.doi.org/10.1016/j.psychres.2015.04.030
Henderson, T., Georgiou-Karistianis, N., White, O., Millist, L., Williams,
D. R., Churchyard, A., & Fielding, J. (2011). Inhibitory control during
smooth pursuit in Parkinson’s disease and Huntington’s disease. Movement Disorders, 26, 1893–1899. http://dx.doi.org/10.1002/mds.23757
Lawrence, A. D., Sahakian, B. J., Hodges, J. R., Rosser, A. E., Lange,
K. W., & Robbins, T. W. (1996). Executive and mnemonic functions in
early Huntington’s disease. Brain, 119, 1633–1645. http://dx.doi.org/10
.1093/brain/119.5.1633
Lemiere, J., Decruyenaere, M., Evers-Kiebooms, G., Vandenbussche, E.,
& Dom, R. (2004). Cognitive changes in patients with Huntington’s
disease (HD) and asymptomatic carriers of the HD mutation: A longitudinal follow-up study. Journal of Neurology, 251, 935–942. http://dx
.doi.org/10.1007/s00415-004-0461-9
Ljubisavljevic, M. R., Ismail, F. Y., & Filipovic, S. (2013). Transcranial
magnetic stimulation of degenerating brain: A comparison of normal
aging, Alzheimer’s, Parkinson’s and Huntington’s disease. Current Alzheimer Research, 10, 578 –596. http://dx.doi.org/10.2174/156720
50113109990133
Lyche, P., Jonassen, R., Stiles, T. C., Ulleberg, P., & Landrø, N. I. (2011).
Attentional functions in major depressive disorders with and without
comorbid anxiety. Archives of Clinical Neuropsychology, 26, 38 – 47.
http://dx.doi.org/10.1093/arclin/acq095
MacLeod, J. W., Lawrence, M. A., McConnell, M. M., Eskes, G. A., Klein,
R. M., & Shore, D. I. (2010). Appraising the ANT: Psychometric and
theoretical considerations of the attention network test. Neuropsychology, 24, 637– 651. http://dx.doi.org/10.1037/a0019803
Mahoney, J. R., Verghese, J., Goldin, Y., Lipton, R., & Holtzer, R. (2010).
Alerting, orienting, and executive attention in older adults. Journal of the
International Neuropsychological Society, 16, 877– 889. http://dx.doi
.org/10.1017/S1355617710000767
Malejko, K., Weydt, P., Süßmuth, S. D., Grön, G., Landwehrmeyer, B. G.,
& Abler, B. (2014). Prodromal Huntington disease as a model for
functional compensation of early neurodegeneration. PLoS ONE, 9,
e114569. http://dx.doi.org/10.1371/journal.pone.0114569
Matsui, J. T., Vaidya, J. G., Johnson, H. J., Magnotta, V. A., Long, J. D.,
Mills, J. A., . . . Paulsen, J. S. (2014). Diffusion weighted imaging of
prefrontal cortex in prodromal Huntington’s disease. Human Brain Mapping, 35, 1562–1573. http://dx.doi.org/10.1002/hbm.22273
Maurage, P., de Timary, P., Billieux, J., Collignon, M., & Heeren, A.
(2014). Attentional alterations in alcohol dependence are underpinned by
specific executive control deficits. Alcoholism: Clinical and Experimental Research, 38, 2105–2112. http://dx.doi.org/10.1111/acer.12444
Maurage, P., Lahaye, M., Grynberg, D., Jeanjean, A., Guettat, L., VerellenDumoulin, C., . . . Constant, E. (2016). Dissociating emotional and
cognitive empathy in pre-clinical and clinical Huntington’s disease.
Psychiatry Research, 237, 103–108. http://dx.doi.org/10.1016/j.psychres
.2016.01.070
Medina, F. J., & Túnez, I. (2010). Huntington’s disease: The value of
transcranial magnetic stimulation. Current Medicinal Chemistry, 17,
2482–2491. http://dx.doi.org/10.2174/092986710791556078
Moriya, J., & Tanno, Y. (2009). Dysfunction of attentional networks for
non-emotional processing in negative affect. Cognition and Emotion, 23,
1090 –1105. http://dx.doi.org/10.1080/02699930802335018
Nopoulos, P. C., Aylward, E. H., Ross, C. A., Johnson, H. J., Magnotta,
V. A., Juhl, A. R., . . . the PREDICT-HD Investigators Coordinators of
Huntington Study Group (HSG). (2010). Cerebral cortex structure in
prodromal Huntington disease. Neurobiology of Disease, 40, 544 –554.
http://dx.doi.org/10.1016/j.nbd.2010.07.014
This document is copyrighted by the American Psychological Association or one of its allied publishers.
This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
12
MAURAGE ET AL.
Orellana, G., Slachevsky, A., & Peña, M. (2012). Executive attention
impairment in first-episode schizophrenia. BMC Psychiatry, 12, 154.
http://dx.doi.org/10.1186/1471-244X-12-154
O’Rourke, J. J., Beglinger, L. J., Smith, M. M., Mills, J., Moser, D. J.,
Rowe, K. C., . . . the PREDICT-HD Investigators of the Huntington
Study Group. (2011). The Trail Making Test in prodromal Huntington
disease: Contributions of disease progression to test performance. Journal of Clinical and Experimental Neuropsychology, 33, 567–579. http://
dx.doi.org/10.1080/13803395.2010.541228
Paulsen, J. S., & Long, J. D. (2014). Onset of Huntington’s disease: Can it
be purely cognitive? Movement Disorders, 29, 1342–1350. http://dx.doi
.org/10.1002/mds.25997
Peretti, C. S., Ferreri, F., Blanchard, F., Bakchine, S., Peretti, C. R.,
Dobrescu, A., . . . Chouinard, G. (2008). Normal and pathological aging
of attention in presymptomatic Huntington’s, Huntington’s and Alzheimer’s disease, and nondemented elderly subjects. Psychotherapy and
Psychosomatics, 77, 139 –146. http://dx.doi.org/10.1159/000116607
Peretti, C. S., Peretti, C., Chouinard, V. A., & Chouinard, G. (2010).
Endogenous attention in normal elderly, presymptomatic Huntington’s
disease and Huntington’s disease subjects. In N. E. Tunali (Ed.), Huntington’s disease—Core concepts and current advances (pp. 233–242).
New York, NY: Intech.
Petersen, S. E., & Posner, M. I. (2012). The attention system of the human
brain: 20 years after. Annual Review of Neuroscience, 35, 73– 89. http://
dx.doi.org/10.1146/annurev-neuro-062111-150525
Piira, A., van Walsem, M. R., Mikalsen, G., Øie, L., Frich, J. C., &
Knutsen, S. (2014). Effects of a two-year intensive multidisciplinary
rehabilitation program for patients with Huntington’s disease: A prospective intervention study. PLoS Currents, 6, 1.
Posner, M. I., & Petersen, S. E. (1990). The attention system of the human
brain. Annual Review of Neuroscience, 13, 25– 42. http://dx.doi.org/10
.1146/annurev.ne.13.030190.000325
Psychology Software Tools. (2012). E-Prime 2.0 (Computer Software).
Retrieved from http://www.pstnet.com
Reading, S. A., Yassa, M. A., Bakker, A., Dziorny, A. C., Gourley, L. M.,
Yallapragada, V., . . . Ross, C. A. (2005). Regional white matter change
in pre-symptomatic Huntington’s disease: A diffusion tensor imaging
study. Psychiatry Research: Neuroimaging, 140, 55– 62. http://dx.doi
.org/10.1016/j.pscychresns.2005.05.011
Roos, R. A. (2010). Huntington’s disease: A clinical review. Orphanet
Journal of Rare Diseases, 5, 40. http://dx.doi.org/10.1186/1750-11725-40
Rosenblatt, A. (2007). Neuropsychiatry of Huntington’s disease. Dialogues
in Clinical Neuroscience, 9, 191–197.
Ross, C. A., & Tabrizi, S. J. (2011). Huntington’s disease: From molecular
pathogenesis to clinical treatment. Lancet Neurology, 10, 83–98. http://
dx.doi.org/10.1016/S1474-4422(10)70245-3
Sapp, E., Schwarz, C., Chase, K., Bhide, P. G., Young, A. B., Penney, J.,
. . . DiFiglia, M. (1997). Huntingtin localization in brains of normal and
Huntington’s disease patients. Annals of Neurology, 42, 604 – 612. http://
dx.doi.org/10.1002/ana.410420411
Say, M. J., Jones, R., Scahill, R. I., Dumas, E. M., Coleman, A., Santos,
R. C., . . . the TRACK-HD Investigators. (2011). Visuomotor integration
deficits precede clinical onset in Huntington’s disease. Neuropsychologia, 49, 264 –270. http://dx.doi.org/10.1016/j.neuropsychologia.2010.11
.016
Serino, A., Ciaramelli, E., Santantonio, A. D., Malagù, S., Servadei, F., &
Làdavas, E. (2007). A pilot study for rehabilitation of central executive
deficits after traumatic brain injury. Brain Injury, 21, 11–19. http://dx
.doi.org/10.1080/02699050601151811
Shallice, T., Stuss, D. T., Alexander, M. P., Picton, T. W., & Derkzen, D.
(2008). The multiple dimensions of sustained attention. Cortex, 44,
794 – 805. http://dx.doi.org/10.1016/j.cortex.2007.04.002
Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J.,
Weiller, E., . . . Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview (M. I. N. I.): The development and validation of a
structured diagnostic psychiatric interview for DSM–IV and ICD-10.
Journal of Clinical Psychiatry, 59(Suppl. 20), 22–33.
Sommerfeldt, S. L., Cullen, K. R., Han, G., Fryza, B. J., Houri, A. K., &
Klimes-Dougan, B. (2016). Executive attention impairment in adolescents with major depressive disorder. Journal of Clinical Child and
Adolescent Psychology, 45, 69 – 83. http://dx.doi.org/10.1080/15374416
.2015.1072823
Spielberger, D. C., Gorsuch, R. L., Lushene, R. L., Vagg, P. R., & Jacobs,
G. A. (1983). Manual for the State-Trait Anxiety Inventory (1st ed.). Palo
Alto, CA: Consulting Psychologists Press.
Sprengelmeyer, R., Lange, H., & Hömberg, V. (1995). The pattern of
attentional deficits in Huntington’s disease. Brain, 118, 145–152. http://
dx.doi.org/10.1093/brain/118.1.145
Stout, J. C., Paulsen, J. S., Queller, S., Solomon, A. C., Whitlock, K. B.,
Campbell, J. C., . . . Aylward, E. H. (2011). Neurocognitive signs in
prodromal Huntington disease. Neuropsychology, 25, 1–14. http://dx.doi
.org/10.1037/a0020937
Sturrock, A., & Leavitt, B. R. (2010). The clinical and genetic features of
Huntington disease. Journal of Geriatric Psychiatry and Neurology, 23,
243–259. http://dx.doi.org/10.1177/0891988710383573
Stuss, D. T., & Alexander, M. P. (2007). Is there a dysexecutive syndrome?
Philosophical Transactions of the Royal Society of London Series B:
Biological Sciences, 362, 901–915. http://dx.doi.org/10.1098/rstb.2007
.2096
Stuss, D. T., Alexander, M. P., Shallice, T., Picton, T. W., Binns, M. A.,
Macdonald, R., . . . Katz, D. I. (2005). Multiple frontal systems controlling response speed. Neuropsychologia, 43, 396 – 417. http://dx.doi
.org/10.1016/j.neuropsychologia.2004.06.010
Stuss, D. T., Shallice, T., Alexander, M. P., & Picton, T. W. (1995). A
multidisciplinary approach to anterior attentional functions. Annals of
the New York Academy of Sciences, 769, 191–212. http://dx.doi.org/10
.1111/j.1749-6632.1995.tb38140.x
Thimm, M., Fink, G. R., Küst, J., Karbe, H., & Sturm, W. (2006). Impact
of alertness training on spatial neglect: A behavioural and fMRI study.
Neuropsychologia, 44, 1230 –1246. http://dx.doi.org/10.1016/j
.neuropsychologia.2005.09.008
Thompson, J. C., Poliakoff, E., Sollom, A. C., Howard, E., Craufurd, D.,
& Snowden, J. S. (2010). Automaticity and attention in Huntington’s
disease: When two hands are not better than one. Neuropsychologia, 48,
171–178. http://dx.doi.org/10.1016/j.neuropsychologia.2009.09.002
Tortella-Feliu, M., Morillas-Romero, A., Balle, M., Bornas, X., Llabrés, J.,
& Pacheco-Unguetti, A. P. (2014). Attentional control, attentional network functioning, and emotion regulation styles. Cognition and Emotion, 28, 769 –780. http://dx.doi.org/10.1080/02699931.2013.860889
Urbanek, C., Weinges-Evers, N., Bellmann-Strobl, J., Bock, M., Dörr, J.,
Hahn, E., . . . Paul, F. (2010). Attention network test reveals alerting
network dysfunction in multiple sclerosis. Multiple Sclerosis Journal,
16, 93–99. http://dx.doi.org/10.1177/1352458509350308
van Duijn, E., Kingma, E. M., & van der Mast, R. C. (2007). Psychopathology in verified Huntington’s disease gene carriers. Journal of Neuropsychiatry and Clinical Neurosciences, 19, 441– 448. http://dx.doi
.org/10.1176/jnp.2007.19.4.441
Veenhuizen, R. B., Kootstra, B., Vink, W., Posthumus, J., van Bekkum, P.,
Zijlstra, M., & Dokter, J. (2011). Coordinated multidisciplinary care for
ambulatory Huntington’s disease patients: Evaluation of 18 months of
implementation. Orphanet Journal of Rare Diseases, 6, 77. http://dx.doi
.org/10.1186/1750-1172-6-77
Verny, C., Allain, P., Prudean, A., Malinge, M. C., Gohier, B., Scherer, C.,
. . . Le Gall, D. (2007). Cognitive changes in asymptomatic carriers of
the Huntington disease mutation gene. European Journal of Neurology,
14, 1344 –1350. http://dx.doi.org/10.1111/j.1468-1331.2007.01975.x
This document is copyrighted by the American Psychological Association or one of its allied publishers.
This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
ATTENTIONAL NETWORKS IN HUNTINGTON’S DISEASE
Visintin, E., De Panfilis, C., Antonucci, C., Capecci, C., Marchesi, C., &
Sambataro, F. (2015). Parsing the intrinsic networks underlying attention: A resting state study. Behavioural Brain Research, 278, 315–322.
http://dx.doi.org/10.1016/j.bbr.2014.10.002
Wolf, R. C., & Klöppel, S. (2013). Clinical significance of frontal cortex
abnormalities in Huntington’s disease. Experimental Neurology, 247,
39 – 44. http://dx.doi.org/10.1016/j.expneurol.2013.03.022
Wolf, R. C., Sambataro, F., Vasic, N., Wolf, N. D., Thomann, P. A.,
Landwehrmeyer, G. B., & Orth, M. (2011). Longitudinal functional
magnetic resonance imaging of cognition in preclinical Huntington’s
disease. Experimental Neurology, 231, 214 –222. http://dx.doi.org/10
.1016/j.expneurol.2011.06.011
World Medical Association. (2013). WMA declaration of Helsinki: Ethical
principles for medical research involving human subjects. Retrieved
from http://www.wma.net/en/30publications/10policies/b3/
13
Zhou, S., Chen, X., Wang, C., Yin, C., Hu, P., & Wang, K. (2012).
Selective attention deficits in early and moderate stage Parkinson’s
disease. Neuroscience Letters, 509, 50 –55. http://dx.doi.org/10.1016/j
.neulet.2011.12.049
Zinzi, P., Salmaso, D., De Grandis, R., Graziani, G., Maceroni, S., Bentivoglio, A., . . . Jacopini, G. (2007). Effects of an intensive rehabilitation
programme on patients with Huntington’s disease: A pilot study. Clinical Rehabilitation, 21, 603– 613. http://dx.doi.org/10.1177/0269
215507075495
Received October 30, 2015
Revision received August 23, 2016
Accepted September 7, 2016 䡲